Jantien P Brouwer

Summary

Publications

  1. ncbi request reprint Triiodothyronine addition to paroxetine in the treatment of major depressive disorder
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands
    J Clin Endocrinol Metab 89:6271-6. 2004
  2. ncbi request reprint Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands
    Psychoneuroendocrinology 31:1154-63. 2006
  3. ncbi request reprint Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, The Netherlands
    Eur J Endocrinol 154:819-25. 2006
  4. ncbi request reprint Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center of the University of Amsterdam, The Netherlands
    Biol Psychiatry 59:696-701. 2006
  5. ncbi request reprint Thyroid and adrenal axis in major depression: a controlled study in outpatients
    Jantien P Brouwer
    Department of Endocrinology, University of Amsterdam, Amsterdam, The Netherlands
    Eur J Endocrinol 152:185-91. 2005

Detail Information

Publications5

  1. ncbi request reprint Triiodothyronine addition to paroxetine in the treatment of major depressive disorder
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands
    J Clin Endocrinol Metab 89:6271-6. 2004
    ..On the contrary, more adverse reactions occurred in T3-treated patients...
  2. ncbi request reprint Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands
    Psychoneuroendocrinology 31:1154-63. 2006
    ..We investigated whether treatment response is predicted by hypothalamus-pituitary-adrenal (HPA) axis parameters, or by genetic polymorphisms in the glucocorticoid receptor (GR), that regulates its feedback...
  3. ncbi request reprint Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression
    Jantien P Brouwer
    Department of Endocrinology, Academic Medical Center, The Netherlands
    Eur J Endocrinol 154:819-25. 2006
    ....
  4. ncbi request reprint Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression)
    Bente C Appelhof
    Department of Endocrinology and Metabolism, Academic Medical Center of the University of Amsterdam, The Netherlands
    Biol Psychiatry 59:696-701. 2006
    ..Knowledge of pathogenic mechanisms and predictors of relapse in major depressive disorder is still limited. Hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation is thought to be related to the development and course of depression...
  5. ncbi request reprint Thyroid and adrenal axis in major depression: a controlled study in outpatients
    Jantien P Brouwer
    Department of Endocrinology, University of Amsterdam, Amsterdam, The Netherlands
    Eur J Endocrinol 152:185-91. 2005
    ..We therefore conducted a controlled study in unipolar depressed outpatients who had been free of antidepressants for at least 3 months...